Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical studies support potential of CP-358774 as cancer treatment

Feb. 4, 1998

New targets for stroke: neurotrophic growth factors

Feb. 4, 1998

Phase III trial compares immediate and delayed treatment with fomivirsen for CMV retinitis

Feb. 4, 1998

NexMed completes phase I trial of ED product

Feb. 4, 1998

Beneficial effects of vitamin C demonstrated in heart failure patients

Feb. 4, 1998

Strategies for purging latently infected cells in HIV-positive patients studied at NIAID

Feb. 4, 1998

Name change and relocation announced

Feb. 4, 1998

Heterocyclic bradykinin antagonists from Hoechst

Feb. 4, 1998

Hoechst reveals several series of Na+/H+ exchange inhibitors

Feb. 4, 1998

TIMI 12 trial results published

Feb. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...